Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients

Am J Hematol. 2019 Dec;94(12):E317-E319. doi: 10.1002/ajh.25631. Epub 2019 Oct 4.

Authors

Vishal K Gupta¹, Paul S White², Dina Brauneis², Anthony C Shelton², Karen Quillen², Vaishali Sanchorawala², Shayna Sarosiek², John Mark Sloan²

Affiliations

¹ Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
² Stem Cell Transplant Program, Section of Hematology and Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.

PMID: 31489689
DOI: 10.1002/ajh.25631

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Asymptomatic Diseases
Female
HTLV-I Infections / complications*
HTLV-II Infections / complications*
Hematopoietic Stem Cell Transplantation*
Humans
Immunoglobulin Light-chain Amyloidosis / complications
Immunoglobulin Light-chain Amyloidosis / therapy*
Lymphoma, Large B-Cell, Diffuse / complications
Lymphoma, Large B-Cell, Diffuse / therapy*
Male
Middle Aged
Multiple Myeloma / complications
Multiple Myeloma / therapy*
Retrospective Studies
Transplantation, Autologous
Virus Activation